
æ°ããå ±åæžïŒ ãççºçãªãå²åã§ããã§æ»äº¡ããè¥è ãã¡ãè±åœæ¿åºã®ããŒã¿ã§æããã«ã
å èšäºã¯ãã¡ããã/Click here to read the original article.
COVID-19ã¯ã¯ãã³ã®æ¥çš®éå§ä»¥æ¥ãè±åœåœå®¶çµ±èšå±ã®ããŒã¿ã«ããã°ã2021幎ãã2022幎ã«ãããŠãæ¥éã«è»¢ç§»ããæ«æããã«ããè¥è ã®æ»äº¡ããã€ãŠãªãã»ã©å¢å ããŠãããç§ãã¡ã¯ã2020幎ã«ç§ãã¡ã®å¥åº·ãå¿é ããŠããè±åœæ¿åºãšãã® "å¥åº·ã®å°éå®¶ "ãã¡ãããã®ã·ã§ããã³ã°ãªããŒã¿ã«ã€ããŠç·æ¥èª¿æ»ãè¡ãã ãããšæåŸ ããŠããããæ®å¿µãªããããã§ã¯ãªããäºæ³éãæ²é»ãå®ã£ãŠããã
ãããããã®ããŒã¿ã®åæã¯ãå ãã©ãã¯ããã¯ã®ããŒããã©ãªãªã»ãããŒãžã£ãŒã§ããŒã¿ã»ã¢ããªã¹ãã®ãšãã»ããŠããšãããŠãã®ããŒãããŒã®äžäººã§ããã«ã«ãã¹ã»ã¢ã¬ã°ãªã¢ãã圌ã®ãã¥ãŒãããã£ã»ãããžã§ã¯ãã§è¡ã£ããããŠãã«ããã°ãæ¿åºãšä¿éºæ¥çã®ããŒã¿ãçšããŠè±åœãšç±³åœã«ãããéå°æ»äº¡ã調æ»ããçµæããããã®çºççãéåžžã®2ã3åãã§ããããšã倿ãããšããã
ãã®ä»¶ã«é¢ããŠãšãã»ããŠãã«ã€ã³ã¿ãã¥ãŒããããšã®ãããDefenderãã®ãã€ã¯ã»ã«ãããã©åžžååç· åœ¹ã¯ããæžããŠããïŒ
æ°ããå ±åæž è¥è ã®ããæ»äº¡çããççºçãã«äžæãè±åœæ¿åºã®ããŒã¿ã§æããã«

è±åœæ¿åºã®ããŒã¿ãåæãããšãããCOVID-19ã¯ã¯ãã³ã®æ®ååŸã15æ³ãã44æ³ã®ããæ»äº¡è æ°ããã€ãŠãªãã»ã©å¢å ããŠããããšããããŒã¿ã¢ããªã¹ãã®ãšãã¯ãŒãã»ããŠãã«ããæ°ããå ±åæžã«ãã£ãŠæããã«ãªã£ãããã®å ±åæžã«ãã£ãŠããããªã調æ»ãæ±ãã声ãåçããŠããã
è±åœã®20代ã30代ã40代ã®ãã£ãŒã³ãšã€ãžã£ãŒãšè¥è ããCOVID-19ã¯ã¯ãã³ã®é壿¥çš®ãå§ãŸã£ãŠä»¥æ¥ãæ¥éã«è»¢ç§»ããæ«æããã§æ»äº¡ããŠããããšãããšãã¯ãŒãã»ããŠãã«ããæ°ããåæã§æããã«ãªã£ãã
å ãŠã©ãŒã«è¡ã®ãããžãã¡ã³ãã»ãããŒãžã£ãŒã§ãããåå äžæãïŒ 2021幎ãš2022幎ã®çªç¶æ»ã®æµè¡ ãã®èè ã§ãããå ãŠã©ãŒã«è¡ã®ãããžãã¡ã³ãã»ãããŒãžã£ãŒã§ããããŠãæ°ã«ãã45ããŒãžã®å ±åæžã¯ãæ°å幎ã«ãããæ»äº¡çããŒã¿ã®æ¥æ¿ãªé転ã§ãããšããŠãäžéšã®è «çåŠè ãææ ®ãããã
ããŠãæ°ã¯ãè±åœåœå®¶çµ±èšå±ïŒOffice for National StatisticsïŒã®å ¥æããããæ¿åºçµ±èšã«åºã¥ããŠåæããã
Defenderèªã®ã€ã³ã¿ãã¥ãŒã«ãããšãããŠãæ°ã¯ã髿°Žæºã®ç§åŠè ãããŒã¿ã¢ããªã¹ãã財åå°éå®¶ãå«ãç ç©¶ããŒãããŒãšãšãã«ãæªæ§æ°çç©ïŒC00ããC99ã³ãŒãïŒã®åŸåã調æ»ããããã2010幎ãã2022幎ã®èª¿æ»æéã«ãããŠãè±åœã«ãããæ»å ã®åœéçŸç åé¡ç¬¬10æ¹èšçïŒICD-10ïŒã³ãŒãããã¹ãŠèª¿æ»ãããšããã
ICD-10ã³ãŒããšã¯ãäžçä¿å¥æ©é¢ïŒWHOïŒãå®ããè«æ±åŠççšã®åœéçãªå»åž«ã®èšºæãçç¶ãåŠçœ®ã®åé¡ã§ãããæªæ§æ°çç©ãšã¯çæ§è «çã®ããšã§ããã
ããŠãæ°ã«ããã°ã圌ã®ç ç©¶ããŒã ã¯é©ãã¹ããã¿ãŒã³ã«æ°ã¥ãããšããïŒ ãŠã§ãŒã«ãºãšã€ã³ã°ã©ã³ãã«ããã2021幎ãš2022幎ã®é«éœ¢è ã®æ»äº¡ã¯ã»ãŒãã¹ãŠã³ãŒãåãããŠãããã2021幎ã®15æ³ãã44æ³ã®æ»äº¡ã®8ïŒ ã2022幎ã®åå¹Žéœ¢å±€ã®æ»äº¡ã®30ïŒ ã¯ãŸã ã³ãŒãåãããŠããªãã£ãã
ãç é¢ã§æ»äº¡ããå Žåãçãšæ»ã®çè·¡ãæ®ãããæ»ã«è³ã£ãåå ã瀺ãããŸããããè¥ã人ãè»ã®é転äžã«æ»ãã ããéãæ©ããŠããããå¯ãŠããéã«æ»ãã ããããšãæ»å ãç¹å®ããã®ã«æéãããããã
ããŠãæ°ã«ããã°ãæ»å ãäžæã§ããããšã¯ãè¥è ã®éåŽæ»ãšãã ãåé¡ã瀺ããŠãã ããšããã
ããããã³ãŒãã®æ¬ èœãšããæ³šæç¹ãèæ ®ããŠãã2021幎ã®ã³ãŒãåãããæ»äº¡ã®æ®ãã®92ïŒ ã2022幎ã®ã³ãŒãåãããæ»äº¡ã®70ïŒ ããããè¥å¹Žå±€ã«ãããããæ»äº¡ã®åŒ·ãã·ã°ãã«ããæããã«ãªã£ããšåæ°ã¯è¿°ã¹ãã2021幎ã«å§ãŸã£ãæªæ§æ°çç©ã«ããæ»äº¡çã®å€§å¹ ãªå¢å ã¯ã2022幎ã«å€§ããå éããã
ã2022幎ã®éå°æ»äº¡ã®å¢å ã¯çµ±èšçã«éåžžã«ææã§ããïŒæ¥µç«¯ãªäºè±¡ïŒããã®çµæã¯ã2021幎åŸåãããæªæ§æ°çç©ã«ããæ»äº¡ã®å¢å ã«ã€ãªããæ°ããªçŸè±¡ããè±åœã®15æ³ãã44æ³ã®å人ã«èŠãããããšã瀺ããŠãããã
è±åœã«ããã15æ³ãã44æ³ã®2022幎ã®ããæ»äº¡çãæŽå²çæšæºãäžåããšããç ç©¶çµæã«ã¯ä»¥äžã®ãã®ãå«ãŸããïŒ
女æ§ã®ä¹³ããæ»äº¡çã28ïŒ å¢å ã
女æ§ã§ã¯èµèçæ»äº¡çã80ïŒ å¢å ãç·æ§ã§ã¯60ïŒ å¢å ã
çµè žçã«ããæ»äº¡çãç·æ§ã§55ïŒ å¢å ã女æ§ã§41ïŒ å¢å ã
èŽæ»çã¡ã©ããŒããç·æ§ã§120ïŒ å¢å ã女æ§ã§35ïŒ å¢å ã
è³è «çã«ããæ»äº¡ãç·æ§ã§35ïŒ å¢å ã女æ§ã§12ïŒ å¢å ã
ãéšäœã®ç¹å®ããªããããã«ããæ»äº¡çãç·æ§ã§60ïŒ å¢å ã女æ§ã§55ïŒ å¢å ã

ãèšåºç蚌æ ã®ç©ã¿éãããç ç©¶ã«ã€ãªãã£ã
ããŠãæ°ã¯ãããŠãæ°ã®ããŒãããŒã®äžäººã§ããã«ã«ãã¹ã»ã¢ã¬ã°ãªã¢æ°ããæ¿åºããã³ä¿éºæ¥çã®ããŒã¿ãçšããŠè±åœãšç±³åœã«ãããéå°æ»äº¡ã«ã€ããŠèª¿æ»ããHumanity Projectsã®äžã§ã圌ã®å ±åæžãäœæããã
圌ã¯ãCOVID-19ã®ãã³ãããã¯æ¿çãã瀟äŒã®å°éå®¶å¶åºŠãžã®ä¿¡é Œãããã«ç Žå£ããŠããããç®ã®åœããã«ããå ¬å ±æ¿çã®æéãšãããããããŒã¿äž»å°ã®ããããã»ãããžã§ã¯ããå§ãããšããã
ããã°ãã¡ãŒãããã®ä»ã®ã°ããŒãã«ãªå©å®³é¢ä¿è ã«ãã£ãŠãåœãå·ã®æ¿åºèŠå¶æ©é¢ãäŒæ¥ã¡ãã£ã¢ãææ¡ãããŠããç¶æ³ã調æ»ãã圌ã¯ãå ¬å ±ã®å©çã®ã²ãŒãããŒããŒãšããŠæ©èœããç¬ç«ãããšãŒãžã§ã³ããå¿ èŠã ããšæã£ãã
ãç§ãã¡ã¯ãã®ãããªãšãŒãžã§ã³ãã«ãªããåããããªçµæãæ±ããä»ã®åäººãæ©é¢ã«è³ªã®é«ãç ç©¶ãæäŸããã€ããã§ãããšåœŒã¯æžããŠããã
ãã®æ°ããå ±åæžã¯ãè±åœæ»å ãããžã§ã¯ãã«ããã圌ã®3çªç®ã®å ±åæžã§ããããããŸã§ã« ãè±åœ-15-44æ³ã®å¿è¡ç®¡çŸæ£ã«ããæ»äº¡ãšé害ã®åŸå ããš ãè±åœ-15-44æ³ã®å¿è¡ç®¡çŸæ£ã«ããæ»äº¡åŸåãåã ã®æ»å ã®åæ ãã調æ»ããŠããã
è¥å¹Žå±€ã§æ¥å¢ããŠããçãšCOVID-19ã¯ã¯ãã³ãé¢é£ã¥ããèšåºç蚌æ ã®ç©ã¿éãããããŠããææ°ã®ç ç©¶ã«å°ããããšåœŒã¯èšãã
ãçŸåšã説æã®ã€ããªãæ»æçã§ç°åžžãªçïŒã¿ãŒãçãªã©ïŒããç¹ã«è¥å¹Žå±€ã«å€ãçºçããŠãããšããéžè©±ç蚌æ ãå¢å ããŠãããããæã ã¯15æ³ãã44æ³ã®è¥å¹Žå±€ã«çŠç¹ãçµã£ãŠç ç©¶ããŠãããã
ããã®ç ç©¶ã®çŠç¹ã¯ãåã ã®äž»åŒµãéžè©±ã調ã¹ãããšã§ã¯ãªããéå£ã¬ãã«ã§ã®çµ±èšçåæãè¡ããéžè©±ç蚌æ ãç°åžžãã©ãããæããã«ããããšã§ãããã
ããŠãæ°ã¯ããæã ã®åæã§æããã«ãªã£ãé¢ä¿æ§ ããããå»çå°éå®¶ãå人ã®å¥åº·ã®æ ¹æ¬çåŸåãçè§£ããããã®çŸå®ãã§ãã¯ã®åºç€ãšãªã ãããšãæãã§ãããšããã
ããŠãæ°ã®æ¹æ³ã¯ãè±åœåœå®¶çµ±èšå±ã®ããŒã¿ããã2010幎ãã2022幎ã®ã€ã³ã°ã©ã³ããšãŠã§ãŒã«ãºã«ãããããã«èµ·å ããæ»äº¡æ°ãåæããããšã§ãã£ãã
圌ã¯ãCOVID-19ãã³ãããã¯ã®ååŸã§ãéå°æ»äº¡çïŒèгå¯ãããæ»äº¡æ°ãšäºæ³ãããæ»äº¡æ°ã®åºæºå€ãšã®å·®ïŒãæ¯èŒããã
ãã®çµæã2010幎ãã2020幎ãŸã§ã®æ£åžžãªããæ»äº¡çã®åºæºå€ã確ç«ããããã®åå·®ã¯ã»ãšãã©ãªããé©ãã»ã©äžè²«ããŠãããšããã
å ±åæžã®äž»ãªçµæã¯ä»¥äžã®éãã§ããïŒ
女æ§ã§ã¯ä¹³ãããå§åçã«å€ãã15ã44æ³ã®å¥³æ§ã«ãããèŽæ»çãªçã®æãäžè¬çãªåå ã¯ä¹³çã§ããã2022幎ã«ããã女æ§ã®æªæ§è «çã«ããéå°æ»äº¡çå šäœã®çŽ25ïŒ ãå ãããè¶ éæ»äº¡çã«åºã¥ããšã女æ§ã«ãšã£ãŠæ¬¡ã«å±éºãªããã¯çµè žãããšåå®®é žããã§ããã
2022幎ã«ã¯ãè¥ãç·å¥³ãšãã«èŽæ»çãªããæ»äº¡ãåçã«å¢å ããäžæ¹ãè¥ãç·æ§ã®ããæ»äº¡ã¯äžé£ãåãã«å¢å ãããã女æ§ã®ä¹³ããã«å¹æµãããããªæ¯é çãªããã¯ãªãã£ããè³è «çãå€§è žãããèããã¯ã2022幎ã®ç·æ§ã®æ»äº¡ããå¢å ã®30.9ïŒ ãå ããã
ä»ã®èåšãžã®æ¥éãªè»¢ç§»ã瀺ããäžè¬ã«ãã¿ãŒãããããšåŒã°ãããéšäœã®ç¹å®ããªããããã¯ã2022幎ã«ãççºçã«å¢å ããããšããŠãæ°ã¯è¿°ã¹ããããããã®ããã¯ã女æ§ïŒ2021幎ãš2022幎ïŒãšç·æ§ïŒ2022幎ïŒã®äž¡æ¹ã§éåžžã«å€§ããå¢å ããŠãããç¹å®ãããæç¹ã§ãã§ã«è»¢ç§»ããŠããå¯èœæ§ãé«ããæ©ææ€èšºãå¿ èŠãšããªãè¥å¹Žè ãæãããããããã®ããã¯æ¥éã«å¢æ®ããå¯èœæ§ãé«ãã"
ç·æ§ã¯ã2022幎ã«ç®èããæ»äº¡çã118ïŒ ãšå€§å¹ ã«äžæãããããããã®çãçå šäœã«å ããå²åã¯ããã»ã©å€§ãããªãã«ããããããããšããŠãæ°ã
æ¶å管ã®ããã¯ãã2010幎ãã2019幎ã®åŸåãšæ¯èŒããŠã2021幎ãš2022幎ã«ççºçãªå€åãèŠãããããšããŠãæ°ã¯æžããŠããããç¹ã«æ³šç®ãã¹ãã¯ãçµè žïŒåœéã³ãŒãC18ïŒãèïŒC16ïŒãé£éïŒC15ïŒã®ããã§ããããæ¶å管ã«é¢é£ãããããã®çã¯ãéèŠæ§ãå€§å¹ ã«äžæããŠããããã§ããããŸããç·æ§ã«äžé£ãåããªåœ±é¿ãåãŒããŠããããã§ããã
èµèããã¯ãã女æ§ïŒ2022幎ïŒãšç·æ§ïŒ2021幎ãš2022幎ã®äž¡æ¹ïŒã®äž¡æ¹ã§éåžžã«å€§ããªäžæãèŠãããªããããã®ãããããã»ã©åçã«å¢å ããã®ãããªãç·æ§ã§æåã«å¢å ããæ¬¡ã«å¥³æ§ã§å¢å ããã®ãã¯ã調æ»ãå¿ èŠã ãšæãããçåã®äžã€ã§ãããã
ããŠãæ°ã¯ãèªèº«ã®ç ç©¶ã¯2020幎以éã®çã®ãåŸåã«ãããŠèгå¯ãããããã€ãã®ãã¿ãŒã³ãæããã«ããããã®æåã®è©Šã¿ãã§ããããšã匷調ããã
ãããããã®ããŒã¿åæãæäŸãããããã®ïŒãããŠä»ã®ïŒæŽå¯ã«åºã¥ããŠãå»åž«ãå°éç ç©¶è ããããªã調æ»ãè¡ãããšãæãããšåœŒã¯æžããŠããã
COVID泚å°ãšããå¢å ã®é¢é£ã¯ã調ã¹ã䟡å€ãããã
ããŠã©ãŒã»ã«ãŒã ïŒãã€ã¯ã©ãŠãã»ãã¡ã€ã¶ãŒææžåæãããžã§ã¯ããã®ãã©ã³ãã£ã¢ç§åŠãªãŒããŒãšããŠåŒéåŸã«åå ãããè±åœã®åŠè¡å»åž«ãæŸå°ç·ç§å»ãä¹³ããå°éå»ã§ããã¯ãªã¹ã»ãã©ã¯ãŒãºå士ã¯ãè±åœã®ããŒã¿ã¯ ãéåžžã«ãéåžžã«ãæžå¿µãã¹ããã®ã§ãã ããšThe Defenderã«èªã£ãã
ãã©ã¯ãŒãºæ°ã«ããã°ãããŠãæ°ã®èª¿æ»ã¯ããã¡ã€ã¶ãŒç€Ÿãšã¢ãã瀟ã®å®éšçmRNAã¯ã¯ãã³ã®äžççå±é以æ¥ãç±³åœãè±åœããããŠè¥¿åŽå é²åœã®ç ç©¶è ãèšåºå»ãã¬ã³å°éå®¶ã«ãã£ãŠå ±åãããã¬ã³æ»äº¡ã®æ¥æ¿ãªå¢å ã«é¢ããåæ§ã®ããŒã¿ãè£ä»ãããã®ã§ãããšã®ããšã§ãããæšå®55.5å人以äžãäžç人å£ã®çŽ72.3ïŒ ãæ¥çš®ãåããã
ãã©ã¯ãŒãºæ°ã¯ãç±³åœãšè±åœã®ç çå»ãæŸå°ç·å»ãè «çå»ãå ç§å»ãéçæ²»çå»ãç ç©¶è ãå«ã圌ã®ååãã¡ã¯ã2022幎ã«ççºçã«å¢å ããè¥å¹Žå±€ã®èŽåœçãªä¹³çããã®ä»ã®çã®æ·±å»ãã®ãããªãã®ãèŠãããšããªããšè¿°ã¹ãã
ããŠãæ°ã®å ±åã¯ããã©ã¯ãŒãºæ°ãã1幎以äžåããæ°ã¥ããŠããããšãè£ä»ãããã®ã§ããïŒ ãéåžžã®2ã3åã®ãããçºçããŠãããã
ãè¥ã人ãã¡ãã€ãŸã20æãã30æã®å¥³æ§ã§ãéåžžæçµãå§ãŸã£ãåŸã§ãããäœããã®æé·ä¿é²ç©è³ªãæ£åžžã«äœçšããŠãã人ãã¡ããæ²»çãå°é£ãªé²è¡ããè «çãåããŠããã®ã§ããçšã§ãã£ããã®ããä»ã§ã¯æ¯èŒçäžè¬çã«ãªã£ãŠãããã
ããããæãææ ®ãã¹ãããšã¯ãäžéšã®è «çå»ãçŸåš ãã¿ãŒãç ããšåŒãã§ããæ°ããçšèªã®è¥è ã®å¢å ã§ããããšãã©ã¯ãŒãºæ°ã¯èšãã
ãã¿ãŒãçãšã¯ãããã€ãã®äºæã衚ãããã«äœãããé èªã§ãããã¿ãŒãçãšã¯ãè¥ã人ãã¡ã®çã®ããšã§ãããæ¥ã¯å æ°ã ã£ãã®ã«ãæ¬¡ã®æ¥ã«ã¯æ«æçã§1é±é以å ã«æ»ã¬ãšå®£åããããäž»èŠã¡ãã£ã¢ã§ããããã®ãããªå ±éãå€ãã®ã§ãã
ãè «çã®å¢æ®ãæ©ããªã£ãã ãã§ãªããåã人ã«çºçããããã®çš®é¡ãå¢ããŠããŸãã以åã¯éåžžã«ãŸãã§ãããããŸã«ãè¥ã人ã«éåžžã«æ»æçãªççæ§ãããèŠãããšãããã ãã§ãããããããä»ã§ã¯èª°ããçµéšããããã«ãªããŸããã
Frontline COVID-19 Critical Care AllianceïŒFLCCCïŒã®äŒé·å Œã¡ãã£ã«ã«ã»ãã£ã¬ã¯ã¿ãŒã§ããã蚺çæã§ã¯æ°çŸäººã®ã¯ã¯ãã³å·å®³æ£è ãæ²»çããŠããåŒåžåšå°éå»ã§éçæ²»çå»ã®ããšãŒã«ã»ã³ãªãŒå士ã¯ãååãæ£è ããããã®å¢å ã«é¢ãããå ±åãå©ããæ±ããçžè«ã殺å°ããŠããããšèªã£ãã
å®éšç çåŠã®å士å·ãæã€è¬å€åž«ã§ãããåœåã¯ãžã§ã³ãœã³ã»ãšã³ãã»ãžã§ã³ãœã³ç€Ÿã§è¡åŸã®å èæå·ãäºé²ãã補åã®ãã€ãªãã¢ã§ãã£ããã€ãããã»ã¯ã€ãºãã³å士ã¯ã圌ãšMITããã²ãã ã»ãããžã§ã¯ãã®å ç ç©¶éçºè²¬ä»»è ã±ãã³ã»ããã«ãŒãã³ãè¡ã£ããmRNA泚å°ã«DNAæçãæ··å ¥ããŠããããšã瀺ãç ç©¶ããæ¿åºãäž»èŠã¡ãã£ã¢ã远究ããããšããªãããšã«ãé©ããšæ€ãã亀äºã«æããŠãããšè¿°ã¹ãã
ã¯ã€ãºãã³æ°ã«ããã°ããããã®æçã¯ã¯ã¯ãã³ãããã²ãã ã«äžããå¯èœæ§ã®ãããã¡ãŒãžã«å ããã¬ã³ãå«ãæ§ã ãªåé¡ãžã®æ°ããªæãéãããšã«ãªããšããã
ã¯ã€ãºãã³ã¯ãDefenderãçŽã«ãçŸç 察çäºé²ã»ã³ã¿ãŒïŒCDCïŒèªèº«ã®ããŒã¿ããCOVID-19ã¯ã¯ãã³ã«é¢é£ããçã®æžå¿µã瀺ããŠãããšèªã£ãã
ç±³åœé£åå»è¬åå±ïŒFDAïŒãšCDCã®å ¬åŒã®ã¯ã¯ãã³è¢«å®³å ±åãµã€ãã§ããVAERSã§ã¯ãã¬ã³ã®å¢å ã確èªãããŠããŸããCDCã¯PRRåæïŒã·ã°ãã«åæïŒãè¡ããã¯ã¯ãã³ã«çã®ã·ã°ãã«ãçºèŠããŸããã